Home >> Proteins >> Enzymes

Enzymes(酶)

Enzymes are very efficient and specific catalyst proteins which react with 1 or few types of substrates in biochemical reactions and are responsible for bringing about almost all of the chemical reactions in living organisms. Enzymes speed up reactions by providing an alternative reaction pathway of lower activation energy. Without enzymes, reactions take place at a rate far too slow for the pace of metabolism which means that they speed up the chemical reactions in living things.

There are 2 types of enzymes, ones that help join specific molecules together to form new molecules & others that help break specific molecules apart into separate molecules. Enzymes play many important roles ouside the cell as well. One of the best examples of this is the digestive system. For instance, it is enzymes in your digestive system that break food down in your digestive system break food down into small molecules that can be absorbed by the body. Some enzymes in your digestive system break down starch, some proteins and others break down fats. The enzymes used to digest our food are extra-cellular since they are located outside our cells & enzymes inside our cells are intra-cellular enzymes. Enzymes are used in ALL chemical reactions in living things; this includes respiration, photosynthesis, movement growth, getting rid of toxic chemicals in the liver and so on. Enzymes are proteins that must have the correct structure to be active. They are very easily affected by heat, pH and heavy metal ions.

Ribonucleoprotein enzyme catalytic activity is located in the protein part but for some the catalytic activity is in the RNA part. A catalyst is any substance which makes a chemical reaction go faster, without itself being changed. A catalyst can be used over and over again in a chemical reaction and does not get used up.

Enzymes lower the amount of activation energy needed by binding to the reactants of the reaction they catalyze, thus speed up the reaction and can process millions of molecules per second. Enzymes are typically large proteins with high molecular weight that permit reactions to go at conditions that the body can tolerate.

Enzyme nomenclature is based on what the enzyme reacts with & how it reacts along with the ending ase.

Enzymes must get over the activation energy hurdle.

Enzymes change how a reaction will proceed which reduces the activation energy and makes it faster. The more we increase the enzyme concentration the faster the reaction rate for non-catalyzed reactions. Enzymes that are catalyzed reactions also increase reaction rate at higher level of concentration but up to a certain point called Vmax which means that the enzyme has reached its maximum point. The reaction is limited by both the concentrations of the enzyme and substrate. Enzymes as catalysts take part in reactions which provide an alternative reaction pathway. Enzymes do not undergo permanent changes and remain unchanged at the end of the reaction. They only change the rate of reaction, not the position of the equilibrium.Enzymes as catalysts are highly selective by only catalysing specific reactions due to the shapes of the enzyme’s molecule.

Enzymes contain a globular protein part called apoenzyme and a non-protein part named cofactor or prosthetic group or metal-ion-activator. Changes in temperature and pH have great influence on the intra- and intermolecular bonds that hold the protein part in their secondary and tertiary structures.

Examples of cofactors are 1. Prosthetic group that are permanently bound to the enzyme. 2. Activator group which are cations (positively charged metal ions) & temporarily bind to the active site of the enzyme. 3.Coenzymes, usually vitamins or made from vitamins which are not permanently bound to the enzyme molecule, but combine with the enzyme-substrate complex temporarily. Enzymes require the presence cofactors before their catalytic activity can be exerted. This entire active complex is referred to as the holoenzyme.

Without enzymes, our guts would take weeks to digest our food, our muscles, nerves and bones would not work properly and so on…

Main Enzyme category groups:

Oxidoreductases:
All enzymes that catalyse oxido-reductions belong in this class. The substrate oxidized is regarded as a hydrogen or electron donor. The classification is based on 'donor:acceptor oxidoreductase'. The common name is 'dehydrogenase', wherever this is possible; as an alternative, 'acceptor reductase' can be used. 'Oxidase' is used only where O2 is an acceptor. Classification is difficult in some cases, because of the lack of specificity towards the acceptor.

Transferases:
Transferases are enzymes that transfer a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme 'donor:acceptor grouptransferase'. The common names are normally formed as 'acceptor grouptransferase' or 'donor grouptransferase'. In many cases, the donor is a cofactor (coenzyme) that carries the group to be transferred. The aminotransferases constitute a special case.

Hydrolases:
These enzymes catalyse the hydrolysis of various bonds. Some of these enzymes pose problems because they have a very wide specificity, and it is not easy to decide if two preparations described by different authors are the same, or if they should be listed under different entries. While the systematic name always includes 'hydrolase', the common name is, in most cases, formed by the name of the substrate with the suffix -ase. It is understood that the name of the substrate with this suffix, and no other indicator, means a hydrolytic enzyme. It should be noted that peptidases have recommended names rather than common names.

Lyases:
Lyases are enzymes that cleave C-C, C-O, C-N and other bonds by means other than by hydrolysis or oxidation. They differ from other enzymes in that two (or more) substrates are involved in one reaction direction, but there is one compound fewer in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring. The systematic name is formed according to 'substrate group-lyase'. In common names, expressions like decarboxylase, aldolase, etc. are used. 'Dehydratase' is used for those enzymes that eliminate water. In cases where the reverse reaction is the more important, or the only one to be demonstrated, 'synthase' may be used in the name.

Ligases:
Ligases are enzymes that catalyse the joining of two molecules with concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate. 'Ligase' is often used for the common name, but, in a few cases, 'synthase' or 'carboxylase' is used. 'Synthetase' may be used in place of 'synthase' for enzymes in this class.

Products for  Enzymes

  1. Cat.No. 产品名称 Information
  2. GC62570 SHP2-IN-6 hydrochloride SHP2-IN-6 hydrochloride 是一种有效的 SHP2 抑制剂,IC50 值为 25.8 nM,详细信息请参见专利 WO2017211303A1,compound 7。
  3. GC62551 β-Hydroxypropiovanillone β-Hydroxypropiovanillone 是一种天然化合物,对 α-葡萄糖苷酶 (α-glucosidase) 具有明显的浓度依赖性抑制作用 (IC50=257.8 μg/mL)。
  4. GC62487 POMHEX POMHEX 是一个消旋混合物,是具有细胞渗透性的 HEX 的 POM 前体药物,是ENO2 的特异性抑制剂。POMHEX 对ENO1 缺失的细胞表现出低纳摩尔级别活性,并对 ENO1 缺失的肿瘤模型表现出良好的抗癌效果。POMHEX 是有效的糖酵解抑制剂。
  5. GC62482 TAS-119 TAS-119 是一种有效的,选择性的,具有口服活性的 Aurora A 抑制剂,IC50 为 1.0 nM。TAS-119 对 Aurora A 的选择性高于其他蛋白激酶,包括 Aurora B (IC50 为 95 nM)。TAS-119 具有有效的抗肿瘤活性。
  6. GC62442 Casein Kinase inhibitor A51 Casein Kinase inhibitor A51 是一种有效且具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂。Casein Kinase inhibitor A51 可诱导白血病细胞凋亡 (apoptosis),并具有有效的抗白血病活性。
  7. GC62433 AKI603 AKI-603 is an inhibitor of Aurora kinase A (AurA), which is developed to overcome resistance mediated by BCR-ABL-T315I mutation.
  8. GC62399 RA375 RA375 是 RPN13 (26S 蛋白酶体亚基) 抑制剂。RA375 激活 UPR 信号、ROS 产生和凋亡。RA375 的抗肿瘤活性是 RA190的 10 倍。
  9. GC62347 CMC2.24 CMC2.24 (TRB-N0224) 是一种口服活性三羰基甲烷制剂,通过抑制 Ras 及其下游效应子 ERK1/2 途径对小鼠胰腺肿瘤有效。CMC2.24 也是一种有效的锌依赖性 MMPs 抑制剂,IC50 范围为 2.0-69 μM。CMC2.24 通过恢复软骨内稳态和通过NF-κB/HIF-2α 轴抑制软骨细胞凋亡来减轻骨关节炎的进展。
  10. GC62345 IACS-13909 IACS-13909 is a specific and potent allosteric inhibitor of SHP2 (Src homology 2 domain-containing phosphatase) that suppresses signaling through the MAPK pathway.
  11. GC62337 CK2 inhibitor 2 CK2 inhibitor 2 是一种有效的,选择性和具有口服活性的 CK2 抑制剂,IC50 值为 0.66 nM。CK2 inhibitor 2 对 Clk2 (IC50=32.69 nM)/CK2 显示出高选择性。 CK2 inhibitor 2 具有良好的抗增殖和抗肿瘤活性。
  12. GC62302 Cysteine protease inhibitor-2 Cysteine protease inhibitor-2 是一种半胱氨酸蛋白酶 (cysteine protease) 抑制剂,详细信息请参考专利文献 US20070032499A1中的化合物 12。
  13. GC62286 NCGC00378430 NCGC00378430 is an inhibitor of the SIX1/EYA2 complex that significantly suppresses breast cancer-associated metastasis in vivo without significantly altering primary tumor growth.
  14. GC62239 Zetomipzomib KZR-616 是首创的免疫蛋白酶体 (immunoproteasome) 抑制剂,选择性靶向免疫蛋白酶体亚基 LMP7 (IC50: 39/57 nM=hLMP7/mLMP7) 和 LMP2 (IC50: 131/179 nM=hLMP7/mLMP7)。KZR-616 用于多种自身免疫性疾病的潜力。
  15. GC62210 ONX-0914 TFA A selective inhibitor of the β5i (LMP7) subunit of the immunoproteasome
  16. GC62193 (1S,2S)-Bortezomib (1S,2S)-Bortezomib 是 Bortezomib 的对映异构体。Bortezomib 是一种细胞渗透性、可逆性和选择性的蛋白酶体抑制剂,通过靶向苏氨酸残基有效抑制 20S 蛋白酶体 (Ki 为 0.6 nM)。Bortezomib 破坏细胞周期、诱导细胞凋亡以及抑制核因子 NF-κB。Bortezomib 是一种抗癌药物,也是第一种用于人类的蛋白酶体抑制剂。
  17. GC62191 TD52 A derivative of erlotinib
  18. GC62189 CD532 hydrochloride An inhibitor of Aurora A kinase activity and the Aurora A-N-Myc protein-protein interaction
  19. GC62145 Chiauranib Chiauranib (CS2164) selectively inhibits multiple kinase targets aurora B kinase (AURKB), colony-stimulating factor 1 receptor (CSF1R), and vascular endothelial growth factor receptor (VEGFR)/platelet-derived growth factor receptor (PDGFR)/c-Kit , thereby inhibiting the rapid proliferation of tumor cells, enhancing the antitumor immunity, and inhibiting tumor angiogenesis, to achieve the anti-tumor efficacy.
  20. GC61945 PR-924 PR-924 是一种选择性三肽环氧酮免疫蛋白酶亚单位 LMP-7 的抑制剂,IC50 为 22 nM。PR-924 共价修饰蛋白酶体的 N 端苏氨酸活性位点。PR-924 在多发性骨髓瘤细胞中抑制细胞生长并触发凋亡 (apoptosis),并具有抗肿瘤活性。
  21. GC59040 FAM alkyne, 5-isomer FAM 炔烃,5-异构体是一种高选择性和灵敏的碱性磷酸酶 (ALP) 荧光生物传感器。
  22. GC61791 SID 26681509 quarterhydrate SID26681509quarterhydrate是一种有效的,可逆的,竞争性的,选择性的人组织蛋白酶L(humancathepsinL)抑制剂,IC50为56nM。SID26681509quarterhydrate抑制Plasmodiumfalciparum的体外繁殖,并抑制Leishmaniamajor,IC50分别为15.4μM和12.5μM。SID26681509quarterhydrate对组织蛋白酶G没有抑制活性。
  23. GC61697 Naringinase Naringinase是一种水解酶复合物,具有α-L-鼠李糖苷酶和β-D-葡萄糖苷酶的活性。Naringinase在自然界中广泛存在。Naringinase可用于类固醇,抗生素的生物转化,主要用于糖苷的水解。
  24. GC61635 Kaempferol-7-O-rhamnoside Kaempferol-7-O-rhamnoside是从ChimonanthusnitensOliv叶子中分离的,一种有效的α-葡萄糖苷酶活性抑制剂。Kaempferol-7-O-rhamnoside有用于糖尿病的潜力。
  25. GC61621 NAZ2329 NAZ2329是受体型蛋白质酪氨酸磷酸酶(RPTPs)R5亚家族的第一个细胞可渗透抑制剂,相对于其他PTPs,它变构且优先抑制PTPRZ(hPTPRZ1的IC50=7.5µM)和PTPRG(hPTPRGIC50=4.8µM)。NAZ2329与PTPRZ的D1结构域结合,相对于PTPRZ整个(D1+D2)片段,其更有效地抑制PTPRZ1-D1片段,其IC50为1.1µM。NAZ2329可有效抑制胶质母细胞瘤细胞的肿瘤生长并抑制干细胞样特性。
  26. GC61609 PHPS1 sodium A selective SHP-2 inhibitor
  27. GC61578 L-690330 hydrate L-690330hydrate是一种竞争性的肌醇单磷酸酶(inositolmonophosphatase(IMPase))抑制剂,对重组人和牛IMPase的Ki值为0.27μM和0.19μM,对人和牛前脑皮层IMPase的为Ki值为0.30μM和0.42μM。L-690330hydrate对其敏感性是大鼠和小鼠的IMPase的10倍。
  28. GC61524 SC-43 An SHP-1 activator
  29. GC61408 MLS000544460 MLS000544460是一种高度选择性和可逆的Eya2磷酸酶抑制剂,Kd为2.0μM,IC50为4μM。MLS000544460抑制Eya2磷酸酶介导的细胞迁移,并具有抗癌活性。
  30. GC61403 NCGC00249987 NCGC00249987是一种高度选择性和变构Eya2的Tyr磷酸酶活性的抑制剂,对Eya2ED和MBP-Eya2FL的IC50分别为3μM和6.9μM。NCGC00249987专门针对肺癌细胞的迁移,侵袭伪足形成和侵袭。
  31. GC48895 Rufinamide-15N-d2 An internal standard for the quantification of rufinamide
  32. GC48889 Methazolamide-d6 An internal standard for the quantification of methazolamide
  33. GC48421 GW 280264X An ADAM17/TACE and ADAM10 inhibitor
  34. GC47441 Hydroflumethiazide-13C-d2 An internal standard for the quantification of hydroflumethiazide
  35. GC47385 Furosemide-d5 An internal standard for the quantification of furosemide
  36. GC47210 Dichlorphenamide-13C6 An internal standard for the quantification of dichlorphenamide
  37. GC46885 Asperglaucide An amide with diverse biological activities
  38. GC46769 Abametapir A building block and an insecticide
  39. GC46351 (S)-CR8 An inhibitor of cyclin-dependent kinases
  40. GC61347 TRC-766 TRC-766是一种RTC-5(TRC-382)的阴性对照。TRC-766可结合蛋白磷酸酶2A(PP2A),但不激活磷酸酶。
  41. GC61242 Resveratroloside Resveratroloside是一种α-glucosidase的竞争新抑制剂,能调节血糖水平。Resveratroloside具有心脏保护作用。
  42. GC61221 PTP1B-IN-9 An inhibitor of the ubiquitin-proteasome system
  43. GC61158 ONO-5334 ONO-5334是一种强效、选择性和口服活性的组织蛋白酶K(cathepsinK)抑制剂,对人、兔和大鼠组织蛋白酶K的作用值分别为0.10nM、0.049nM和0.85nM。ONO-5334是一种有效的抗SAR-COV-2病毒活性的抗病毒化合物,其EC50值为500nM。ONO-5334有潜力用于骨质疏松症以及COVID-19的相关研究。
  44. GC60960 JPM-OEt JPM-OEt是一种广谱的半胱氨酸组织蛋白酶(cysteinecathepsin)抑制剂。JPM-OEt在活性位点共价结合,并且不可逆地抑制半胱氨酸组织蛋白酶家族。具有抗肿瘤活性。
  45. GC60860 FSL-1 TFA

    FSL-1, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection.

  46. GC60802 Eleutherol Eleutherol是从E.americana中分离得到的萘类化合物,具有抗真菌(antifungal)活性。Eleutherol抑制白假丝酵母菌,白色念珠菌,酿酒酵母和新型隐球菌的MIC值在7.8-250µg/mL之间。Eleutherol具有α-葡萄糖苷酶(α-glucosidase)抑制活性,IC50>1.00mM。
  47. GC60706 Chrysophanol triglucoside Chrysophanoltriglucoside是一种从决明子中分离出的蒽醌类化合物,可抑制蛋白酪氨酸磷酸酶1B(PTP1B)和α-glucosidase,IC50值分别为80.17和197.06µM。Chrysophanoltriglucoside具有糖尿病研究的潜力。
  48. GC60647 Bis(maltolato)oxovanadium(IV) BMOV (Bis maltolato oxovanadium, Bis(maltolato)oxovanadium (IV)) is a potent oral vanadium complex with anti-diabetic properties and insulin-mimicking effects.BMOV is shown to improve cardiac dysfunctions in diabetic models.
  49. GC60600 ARL67156 trisodium salt hydrate ARL67156trisodiumsalthydrate是一种ecto-ATPase抑制剂。ARL67156trisodiumsalthydrate是弱的竞争性NTPDase1(CD39),NTPDase3和NPP1抑制剂,Ki分别为11,18和12μM。ARL67156trisodiumsalthydrate可预防体内主动脉瓣钙化。
  50. GC60364 Thienopyridone Thienopyridone 是一种有效的选择性的肝再生磷酸酶 (PRL) 磷酸酶抑制剂,对于 PRL-1,PRL-2 和 PRL-3,IC50 值分别为 173 nM,277 nM 和 128 nM。Thienopyridone 对其他磷酸酶的影响很小。Thienopyridone 可诱导 p130Cas 裂解和细胞凋亡 (apoptosis),并具有抗癌作用。
  51. GC60337 SHP836 SHP836 是一种 SHP2 变构抑制剂,抑制 SHP2 的 IC50 值为 12 μM。

Items 201 to 250 of 1645 total

per page
  1. 3
  2. 4
  3. 5
  4. 6
  5. 7

Set Descending Direction